Health Care & Life Sciences » Pharmaceuticals | Endo International PLC

Endo International PLC | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,617
2,877
3,269
4,010
3,469
2,947
Cost of Goods Sold (COGS) incl. D&A
1,040
1,401
2,076
2,635
2,215
1,596
Gross Income
1,577
1,477
1,193
1,375
1,254
1,351
SG&A Expense
908
948
778
921
763
783
EBIT
669
529
415
455
491
567
Unusual Expense
1,056
1,457
1,422
3,926
1,502
1,036
Non Operating Income/Expense
1
22
54
1
18
55
Interest Expense
175
231
379
456
495
535
Pretax Income
560
1,126
1,438
3,924
1,483
939
Income Tax
24
402
1,137
700
250
23
Consolidated Net Income
536
724
300
3,224
1,233
962
Net Income
536
727
300
3,224
1,233
962
Net Income After Extraordinaries
386
733
895
3,101
430
892
Net Income Available to Common
685
721
1,509
3,347
2,035
1,031
EPS (Basic)
6.05
4.91
7.59
15.03
9.12
4.61
Basic Shares Outstanding
113
147
197
223
223
224
EPS (Diluted)
6.05
4.91
7.59
15.03
9.12
4.61
Diluted Shares Outstanding
113
147
197
223
223
224
EBITDA
907
860
1,036
1,438
1,474
1,291
Non-Operating Interest Income
1
4
6
4
6
13
Minority Interest Expense
-
-
3
-
-
-
Equity in Affiliates (Pretax)
-
8
3
1
1
3

About Endo International

View Profile
Address
Minerva House
Dublin Dublin 4
Ireland
Employees -
Website http://www.endo.com
Updated 07/08/2019
Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.